Australia markets closed

QURE Jan 2023 65.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
At close: 09:30AM EDT
Full screen
Previous close0.2000
Open0.2000
Bid0.0000
Ask0.0000
Strike65.00
Expiry date2023-01-20
Day's range0.2000 - 0.2000
Contract rangeN/A
Volume1
Open interest3
  • GlobeNewswire

    uniQure to Participate in Upcoming Industry Conferences in September

    LEXINGTON, Mass. and AMSTERDAM, Sept. 06, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences: Citi’s 17th Annual BioPharma Conference, September 7 – 8, 2022 Members of uniQure’s management team, including Matt Kapusta, chief executive officer, and Ricardo Dolmetsch, Ph.D., president of research

  • Simply Wall St.

    These Analysts Just Made A Neat Downgrade To Their uniQure N.V. (NASDAQ:QURE) EPS Forecasts

    The latest analyst coverage could presage a bad day for uniQure N.V. ( NASDAQ:QURE ), with the analysts making...

  • Motley Fool

    Why uniQure Stock Is Crashing Today

    Shares of uniQure N.V. (NASDAQ: QURE) are crashing today, down by 32.6% as of 11:19 a.m. ET. The steep decline came after the gene therapy specialist provided its second-quarter update Monday morning. Investors weren't all that interested in uniQure's financial results.